Direct Acting Antivirals in Hepatitis C-Infected Kidney Transplant Recipients: Associations with Long-term Graft Failure and Patient Mortality

BACKGROUND: Direct-acting antiviral (DAA) therapy among hepatitis C virus (HCV)-infected kidney transplant recipients is associated with short-term improvement in protein/creatinine (P/C) ratios, but how HCV cure affects long-term graft outcomes remains unknown. METHODS: This is a retrospective foll...

Descripción completa

Detalles Bibliográficos
Autores principales: Goetsch, Michael R., Tamhane, Ashutosh, Overton, Edgar T., Towns, Graham C., Franco, Ricardo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pathogens and Immunity 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556425/
https://www.ncbi.nlm.nih.gov/pubmed/33089036
http://dx.doi.org/10.20411/pai.v5i1.369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556425/
https://www.ncbi.nlm.nih.gov/pubmed/33089036
http://dx.doi.org/10.20411/pai.v5i1.369

Ejemplares similares